|
End-of-day quote
Other stock markets
|
||
| - GBX | - |
|
| 06-12 | European Stocks Close Higher; German Inflation Cools, UK GDP Contracts | MT |
| 06-12 | GSK's Clonal Myeloid Disorder Treatment Gets Orphan Drug Designation From US, European Regulators | MT |
Basic data
Market Cap (GBX)
79,200,315,537
Market Cap (USD)
106,309,148,372
Net sales (GBP)
32,667,000,000
Net sales (USD)
43,848,322,148
Free-Float
92.3 %
Free-Float capitalization (GBX)
78,922,664,776
Free-Float capitalization (USD)
105,936,462,787
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 106B | |
| -2.41% | +0.14% | +39.53% | +154.43% | 1,010B | |
| +1.07% | +3.48% | +53.75% | +50.64% | 580B | |
| +1.32% | +0.22% | +18.35% | +65.35% | 402B | |
| +0.77% | 0.00% | +19.99% | +16.80% | 330B | |
| -1.42% | -1.44% | +45.50% | +8.37% | 294B | |
| -0.85% | -2.86% | +22.05% | +13.80% | 280B | |
| +0.44% | +3.48% | +24.48% | +34.39% | 281B | |
| +1.66% | +1.20% | -44.67% | -47.49% | 197B | |
| +0.32% | +1.61% | +19.48% | +63.42% | 192B | |
| Average | -0.28% | +0.99% | +22.05% | +39.97% | 367.33B | |
| Weighted average by Cap. | -0.80% | +1.00% | +29.84% | +66.16% |
Historical Quotes: GlaxoSmithKline plc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- GSK Stock
- Stock
- Quotes GlaxoSmithKline plc
Select your edition
All financial news and data tailored to specific country editions
